5-Amino-1MQ vs Pemvidutide

Head-to-head comparison of 5-Amino-1MQ (5-Amino-1-methylquinolinium) and Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

Property5-Amino-1MQPemvidutide
CategoryWeight ManagementWeight Management
Full Name5-Amino-1-methylquinoliniumPemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight178.23 g/molN/A
Half-Life~6 hoursApproximately 1 week
Amino AcidsSmall moleculeN/A
Typical DoseTrial-dependent; once-weekly SC titration
RouteSubcutaneous
Purity>98%≥98%
Studies Count2818
Research StatusActive ResearchClinical

5-Amino-1MQ Benefits

  • Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production

Pemvidutide Benefits

  • appetite suppression
  • body-weight reduction
  • improved liver-fat markers
  • better glycemic control

5-Amino-1MQ Dosing

Research doses: 50-150 mg orally daily. Often cycled 8-12 weeks on, 4 weeks off. Best taken in the morning.

Pemvidutide Dosing

once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose

5-Amino-1MQ Side Effects

  • Generally well-tolerated in preclinical models. Potential mild GI discomfort and headache. Long-term human safety data is limited.

Pemvidutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

5-Amino-1MQ

Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.

Pemvidutide

Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

5-Amino-1MQ stacks with:

AOD-9604MOTS-cCJC-1295

Pemvidutide stacks with:

metformintopiramate
weight-lossNNMT-inhibitorfat-lossmetabolismNAD+glp1glucagondual-agonistobesitymash